至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫藥類雜志引用近萬次，處于行業領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發表科研成果，再次證明GenScript 有能力幫助業內科學家Make research easy.
A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
Cell Res .2022-09;
Yingdan Wang # 1, Wuqiang Zhan # 1, Jiangyan Liu # 1 2, Yanqun Wang # 3, Xiang Zhang 1, Meng Zhang 1, Lin Han 1, Yunping Ma 1, Lu Lu 1, Yumei Wen 1, Zhenguo Chen 1, Jincun Zhao 4 5, Fan Wu 6, Lei Sun 7, Jinghe Huang 8
